Dural Arteriovenous Fistulas Research at China INI

Launched by XUANWU HOSPITAL, BEIJING · Aug 6, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Dural Arteriovenous Fistulas Research at China INI," is focused on studying a condition known as dural arteriovenous fistulas (DAVFs). DAVFs are abnormal connections between blood vessels in the brain that can lead to various health issues. The trial aims to gather more information about DAVFs, especially since most previous studies have been done in different locations and may not fully represent all cases. Researchers are particularly interested in understanding how common this condition is and how it differs from other types of blood vessel malformations in the brain.

To be eligible for this study, participants must be adults who have been diagnosed with DAVFs and admitted to Xuanwu Hospital. This means that if you or someone you know fits this description, you could potentially take part in the trial. Participants can expect to undergo assessments and provide information that will help researchers better understand DAVFs. This study is important because it aims to fill gaps in current knowledge about this condition, which could ultimately lead to better diagnosis and treatment options in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients with DAVFs who were admitted to Xuanwu Hospital.
• Exclusion Criteria:
• • Non-DAVF lesions confirmed by DSA.